MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Pacific Biosciences of California ROA Ratio 2011-2026 | PACB
Annual ROA Ratio Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.68 | -24.58 | -17.57 | -17.78 | -9.03 | 7.1 | -56.85 | -60.23 | -63.98 | -53.94 | -24.18 | -53.13 | -58.22 | -72.84 | -50.11 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.1 | -72.84 | -41.67 |
Quarterly ROA Ratio Pacific Biosciences of California
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.81 | -9.76 | -9.36 | -12.89 | -11.73 | -15.51 | -11.94 | -16.17 | -16.88 | -16.91 | -12.25 | -11.43 | -6.39 | -5.87 | -9.46 | -15.18 | -21.72 | -24.01 | -11.0 | -11.06 | -25.01 | -36.06 | -56.85 | -74.88 | -69.91 | -66.52 | -60.23 | -56.56 | -57.13 | -61.62 | -63.98 | -63.37 | -60.78 | -56.47 | -53.94 | -41.21 | -27.14 | -22.82 | -24.18 | -38.36 | -47.1 | -53.37 | -53.15 | -50.55 | -58.23 | -57.89 | -58.22 | -62.28 | -64.76 | -67.07 | -72.84 | -69.55 | -65.43 | -58.39 | -39.65 | -13.41 | -10.29 | -15.94 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -5.87 | -74.88 | -37.84 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 98.33 | 0.9 % | $ 8.11 B |  Irlanda |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 13.71 | -0.22 % | $ 99.4 M |  Israel |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 155.46 | 1.83 % | $ 7.71 B | USA |
 |
Bioventus
BVS
|
3.33 | $ 8.62 | 0.23 % | $ 574 M | USA |
 |
DexCom
DXCM
|
13.19 | $ 64.24 | -1.56 % | $ 25.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
3.43 | $ 25.56 | 0.95 % | $ 710 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.01 | 3.4 % | $ 906 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | $ 103.57 | 0.29 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
-20.67 | $ 85.49 | 1.75 % | $ 10.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 14.77 | 0.61 % | $ 447 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 17.88 | -6.63 % | $ 2.32 B | USA |
 |
Anixa Biosciences
ANIX
|
-67.95 | $ 2.83 | -1.05 % | $ 91.8 K | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 187.32 | 0.57 % | $ 134 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 164.72 | 1.1 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 118.94 | 2.92 % | $ 18.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 199.7 | -0.46 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
11.3 | $ 111.51 | -0.06 % | $ 33.9 B | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.11 | -0.89 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 9.0 | -0.99 % | $ 255 M | Israel |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.09 | -2.78 % | $ 1.97 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 16.52 | 0.12 % | $ 370 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-37.07 | - | - | $ 79.8 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 450.41 | 1.48 % | $ 13 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 114.22 | 3.11 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 173.74 | 0.49 % | $ 24.2 B |  Schweiz |
 |
Personalis
PSNL
|
-30.08 | $ 6.72 | 1.97 % | $ 398 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 7.88 | -1.25 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-39.28 | $ 187.85 | -1.29 % | $ 18.5 B | USA |
 |
Sotera Health Company
SHC
|
2.39 | $ 13.42 | 0.71 % | $ 3.81 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.19 | 2.59 % | $ 826 M | USA |